Solja Eurola

An Activating STAT 3 Muta tion Causes Neonatal Diabetes through Premature Induction of Pancreatic

N. Morgan, R. D. Hawkins, M. Varjosalo, 2022 .

Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation

Jere Weltner, T. Otonkoski, Kirmo Wartiovaara, 2015, Stem cell reports.

Stabilized dCas 9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation

T. Otonkoski, R. Trokovic, Diego Balboa, 2022 .

An Activating STAT3 Mutation Causes Neonatal Diabetes through Premature Induction of Pancreatic Differentiation.

N. Morgan, R. D. Hawkins, M. Varjosalo, 2017, Cell reports.

Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes

H. Huopio, J. Partanen, E. Galli, 2018, eLife.

Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9.

T. Otonkoski, Diego Balboa, J. Weltner, 2017, Stem cell research.

Thymidylate synthase disruption to limit cell proliferation in cell therapies

T. Otonkoski, J. Saarimäki-Vire, K. Wartiovaara, 2023, bioRxiv.